BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference - Yahoo Finance

Submitted by Anonymous (not verified) on Mon, 05/02/2022 - 11:00

BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference  Yahoo Finance